CCL: 21st "Darmstadt" Molecular Modelling Workshop - May 15-16, 2007 in Erlangen

 Sent to CCL by: [Stefan.Guessregen###sanofi-aventis.com]
 21st "Darmstadt" Molecular Modeling Workshop Computer-Chemie-Centrum,
 91052 Erlangen, Germany Tuesday, May 15 - Wednesday, May 16, 2007
 Dear Colleagues,
 I would like to bring to your attention that the 21st "Darmstadt"
 Molecular Modeling Workshop will be taking place in Erlangen on May 15th and
 16th 2007. The goal of the Workshop is to give young scientists, especially PhD
 students and Post-Docs, the chance to present their current research, industrial
 colleagues are able to gain an overview about ongoing academic research.
 Contributions from all areas of molecular modelling, life sciences to materials,
 are highly welcome.
 We are pleased to announce that the following scientists have agreed to give
 plenary lectures:
 Prof. Thierry Langer (University of Innsbruck)
 Prof. Wilfred van Gunsteren (ETH Zurich)
 For any further information regarding the program, registration, location, and
 accomodation, please refer to the following website:
 http://www.chemie.uni-erlangen.de/ccc/darmstadt.html
 The deadline for registration is 13th April 2007.
 Best regards
 Stefan Guessregen
 Dr. Stefan Guessregen
 Sanofi-Aventis Deutschland GmbH
 Scientific & Medical Affairs / Drug Design Industriepark Hoechst, Building G
 878
 D-65926 Frankfurt am Main
 Germany
 Phone: +49 (69) 305 26 616
 Fax: +49 (69) 305 942 333
 E-Mail: stefan.guessregen*aatt*sanofi-aventis.com
 **************************************************************************************************************************************************************
 Sanofi-Aventis Deutschland GmbH, Sitz der Gesellschaft: Frankfurt am Main,
 Handelsregister: Frankfurt am Main, Abt. B Nr. 40661 Vorsitzender des
 Aufsichtsrats: Hanspeter Spek - Geschäftsführer: Dr. Heinz-Werner
 Meier (Vorsitzender), Dr. Matthias Braun, Hervé Gisserot, Dieter Kohl,
 Prof. Dr. Dr. Werner Kramer, Dr. Martin Siewert
 **************************************************************************************************************************************************************